132 related articles for article (PubMed ID: 2511810)
1. The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles.
Kerin JF
Arch Gynecol Obstet; 1989; 246 Suppl():S45-52. PubMed ID: 2511810
[No Abstract] [Full Text] [Related]
2. Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer.
Ferrier A; Rasweiler JJ; Bedford JM; Prey K; Berkeley AS
Fertil Steril; 1990 Jul; 54(1):90-5. PubMed ID: 2113492
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report.
Cassidenti DL; Sauer MV; Paulson RJ; Ditkoff EC; Rivier J; Yen SS; Lobo RA
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1806-10. PubMed ID: 1750479
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women.
Dodson WC; Walmer DK; Hughes CL; Yancy SE; Haney AF
Obstet Gynecol; 1991 Aug; 78(2):187-90. PubMed ID: 1906152
[TBL] [Abstract][Full Text] [Related]
6. Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis.
Corson SL; Batzer FR; Gocial B; Eisenberg E; Huppert LC; Nelson JR
Fertil Steril; 1992 Mar; 57(3):601-5. PubMed ID: 1740205
[TBL] [Abstract][Full Text] [Related]
7. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins.
Caspi E; Ron-El R; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z
Fertil Steril; 1989 Jan; 51(1):95-9. PubMed ID: 2521328
[TBL] [Abstract][Full Text] [Related]
8. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
Usui A
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
[TBL] [Abstract][Full Text] [Related]
9. Gamete intrafallopian transfer (GIFT) compared with intrauterine insemination in the treatment of unexplained infertility.
Murdoch AP; Harris M; Mahroo M; Williams M; Dunlop W
Br J Obstet Gynaecol; 1991 Nov; 98(11):1107-11. PubMed ID: 1760422
[TBL] [Abstract][Full Text] [Related]
10. Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment.
Radwanska E; Rawlins RG; Tummon I; Maclin V; Binor Z; Dmowski WP
Fertil Steril; 1988 Feb; 49(2):356-9. PubMed ID: 3123281
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuprolide acetate in polycystic ovary syndrome.
Dodson WC; Hughes CL; Yancy SE; Haney AF
Fertil Steril; 1989 Dec; 52(6):915-8. PubMed ID: 2512181
[TBL] [Abstract][Full Text] [Related]
12. [Combined GnRH analogs/hMG/hCG treatment].
Braendle W
Arch Gynecol Obstet; 1989; 245(1-4):931-5. PubMed ID: 2529828
[TBL] [Abstract][Full Text] [Related]
13. [CA-125 serum level in early pregnancy follow hMG/hCG stimulated and unstimulated cycles].
Wilke G; Hinney B; Rath W; Henze C; Wuttke W; Kuhn W
Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):941-6. PubMed ID: 2128287
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment with gonadotrophin releasing hormone agonist and gonadotrophins in poor responders to hyperstimulation for in vitro fertilization (IVF): clinical and endocrine results.
McKenna KM; Foster P; McBain J; Martin M; Johnston WI
Aust N Z J Obstet Gynaecol; 1989 Nov; 29(4):428-32. PubMed ID: 2517193
[TBL] [Abstract][Full Text] [Related]
15. [Continuous pulsatile subcutaneous gonadotropin stimulation in polycystic ovary syndrome: a therapeutic alternative].
Steck T; Würfel W; Witteler M; Albert P
Geburtshilfe Frauenheilkd; 1991 May; 51(5):373-8. PubMed ID: 1907938
[TBL] [Abstract][Full Text] [Related]
16. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
[TBL] [Abstract][Full Text] [Related]
17. Progesterone response to exogenous gonadotropins after suppression with leuprolide acetate in gamete intrafallopian transfer.
Riemann DC; Schoolcraft WB; Sinton EB
J Reprod Med; 1991 Mar; 36(3):190-4. PubMed ID: 1903164
[TBL] [Abstract][Full Text] [Related]
18. In vivo fertilization procedures in infertile women with patent fallopian tubes: a comparison of gamete intrafallopian transfer, combined intrauterine and intraperitoneal insemination, and controlled ovarian hyperstimulation alone.
Abyholm T; Tanbo T; Dale PO; Magnus O
J Assist Reprod Genet; 1992 Feb; 9(1):19-23. PubMed ID: 1617244
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization.
Tsai HD; Chen CM; Lo HY; Chang CC
Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042
[TBL] [Abstract][Full Text] [Related]
20. Opposite responses to the addition of leuprolide acetate to human menopausal gonadotropin therapy in two perimenopausal women.
Check JH; Adelson HG
Int J Fertil; 1990; 35(6):343-6. PubMed ID: 1981209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
